InvestorsHub Logo
Followers 20
Posts 2595
Boards Moderated 0
Alias Born 01/27/2022

Re: TalShu post# 424543

Friday, 05/24/2024 7:50:00 PM

Friday, May 24, 2024 7:50:00 PM

Post# of 426240
TalShu, that was a great article. Great find. Very eye-opening. And it's suggestions seem to have both positive and negative implications for Amarin.

But it's clear that Denner has a strategy with CVD.

It seems to me that he is "swinging for the fences", so to speak. The writer indicating that "common diseases" such as CVD affect so many people, that you need to treat a very large portion of the population for the drug to have a positive economic impact. But at the same time, insurers are less willing to reimburse for that type of drug unless it is inexpensive (ie. statins, vaccines, etc.).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News